Reproductive Biology and Endocrinology Open Access New Discoveries on the Biology and Detection of Human Chorionic Gonadotropin Background

Human chorionic gonadotropin (hCG) is a glycoprotein hormone comprising 2 subunits, alpha and beta joined non covalently. While similar in structure to luteinizing hormone (LH), hCG exists in multiple hormonal and non-endocrine agents, rather than as a single molecule like LH and the other glycoprotein hormones. These are regular hCG, hyperglycosylated hCG and the free beta-subunit of hyperglycosylated hCG.For 88 years regular hCG has been known as a promoter of corpus luteal progesterone production, even though this function only explains 3 weeks of a full gestations production of regular hCG. Research in recent years has explained the full gestational production by demonstration of critical functions in trophoblast differentiation and in fetal nutrition through myometrial spiral artery angiogenesis.While regular hCG is made by fused villous syncytiotrophoblast cells, extravillous invasive cytotrophoblast cells make the variant hyperglycosylated hCG. This variant is an autocrine factor, acting on extravillous invasive cytotrophoblast cells to initiate and control invasion as occurs at implantation of pregnancy and the establishment of hemochorial placentation, and malignancy as occurs in invasive hydatidiform mole and choriocarcinoma. Hyperglycosylated hCG inhibits apoptosis in extravillous invasive cytotrophoblast cells promoting cell invasion, growth and malignancy. Other non-trophoblastic malignancies retro-differentiate and produce a hyperglycosylated free beta-subunit of hCG (hCG free beta). This has been shown to be an autocrine factor antagonizing apoptosis furthering cancer cell growth and malignancy.New applications have been demonstrated for total hCG measurements and detection of the 3 hCG variants in pregnancy detection, monitoring pregnancy outcome, determining risk for Down syndrome fetus, predicting preeclampsia, detecting pituitary hCG, detecting and managing gestational trophoblastic diseases, diagnosing quiescent gestational trophoblastic disease, diagnosing placental site trophoblastic tumor, managing testicular germ cell malignancies, and monitoring other human malignancies. There are very few molecules with such wide and varying functions as regular hCG and its variants, and very few tests with such a wide spectrum of clinical applications as total hCG.

[1]  J. Lin,et al.  Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. , 1993, Endocrinology.

[2]  B. Weintraub,et al.  Stimulation of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate of ectopic production of the free beta subunit of chorionic gonadotropin by a human brain tumor cell line. , 1980, Cancer research.

[3]  G. Ross,et al.  Radioimmunoassay for Luteinizing Hormone in Human plasma Or Serum: Physiological Studies* , 1967 .

[4]  W. Luckett Comparative development and evolution of the placenta in primates. , 1974, Contributions to primatology.

[5]  L. Cole The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma HCG. , 1987, The Journal of clinical endocrinology and metabolism.

[6]  L. Cole,et al.  The need for a quantitative urine hCG assay. , 2009, Clinical biochemistry.

[7]  D. Dunson,et al.  Natural limits of pregnancy testing in relation to the expected menstrual period. , 2001, JAMA.

[8]  L. Cole,et al.  Following metastatic placental site trophoblastic tumor with urine beta-core fragment. , 1999, Gynecologic oncology.

[9]  X. Wen,et al.  hCGβ expression by cervical squamous carcinoma –in vivo histological association with tumour invasion and apoptosis , 2008, Histopathology.

[10]  P. Franchimont,et al.  Ectopic Production of Human Chorionic Gonadotropin and Its α- and β-Subunits , 1978 .

[11]  A. Enders,et al.  Structural interactions of trophoblast and uterus during hemochorial placenta formation. , 1993, The Journal of experimental zoology.

[12]  L. Cole,et al.  Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers. , 1988, Gynecologic oncology.

[13]  A. Parlow,et al.  Measurement of human luteinizing hormone in plasma by radioimmunoassay. , 1968, The Journal of clinical investigation.

[14]  R. Hussa,et al.  Discordant Human Chorionic Gonadotropin Results: Causes and Solutions , 1985, Obstetrics and gynecology.

[15]  R. Pandian,et al.  Fully automated chemiluminometric assay for hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen). , 2003, Clinical chemistry.

[16]  R. Martin Scaling of the Mammalian Brain: the Maternal Energy Hypothesis , 1996 .

[17]  Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[18]  D S Newberger,et al.  Down syndrome: prenatal risk assessment and diagnosis. , 2000, American family physician.

[19]  G. Hollweg,et al.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage , 1996, Virchows Archiv.

[20]  O. P. Bahl,et al.  Dissociation and recombination of the subunits of human chorionic gonadotropin. , 1970, Biochemical and biophysical research communications.

[21]  S. Steigrad Epidemiology of gestational trophoblastic diseases. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[22]  P. Ylöstalo,et al.  Early screening for ectopic pregnancy in high-risk symptom-free women , 1994, The Lancet.

[23]  S. Amr,et al.  Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans. , 1984, The Journal of clinical endocrinology and metabolism.

[24]  L. Cole,et al.  The structures of the serine-linked sugar chains on human chorionic gonadotropin. , 1985, Biochemical and biophysical research communications.

[25]  G. Bepler,et al.  Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. , 1991, Cancer letters.

[26]  F. Batzer,et al.  Hormonal evaluation of early pregnancy. , 1980, Fertility and sterility.

[27]  S. Mizutani,et al.  Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. , 2004, Gynecologic oncology.

[28]  U. Stenman,et al.  The use of monoclonal antibodies against human chorionic gonadotropin for immunoperoxidase staining of normal placenta, pituitary gland, and pituitary adenomas. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  E. Staun-ram,et al.  Reproductive Biology and Endocrinology Open Access Human Trophoblast Function during the Implantation Process , 2022 .

[30]  S. Mathieu,et al.  The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation , 2000, British Journal of Cancer.

[31]  R. Ruddon,et al.  Characterization of the intracellular and secreted forms of the glycoprotein hormone chorionic gonadotropin produced by human malignant cells. , 1981, The Journal of biological chemistry.

[32]  L. Cole,et al.  Use of glycosidase digested human chorionic gonadotropin beta-subunit to explain the partial binding of ectopic glycoprotein hormones to Con A. , 1981, Endocrinology.

[33]  P. Stone,et al.  The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. , 2006, Human reproduction update.

[34]  R. Shownkeen,et al.  Studies of the human chorionic gonadotrophin-like substance of human pituitary glands and its significance. , 1983, The Journal of endocrinology.

[35]  L. Cole,et al.  The deactivation of hCG by nicking and dissociation. , 1993, The Journal of clinical endocrinology and metabolism.

[36]  N. Bersinger,et al.  Serum Hyperglycosylated Human Chorionic Gonadotropin to Predict the Gestational Outcome in in vitro Fertilization/Intracytoplasmic Sperm Injection Pregnancies , 2008, Fetal Diagnosis and Therapy.

[37]  K. Grzeschik,et al.  Chromosome assignment of genes encoding theα andΒ subunits of glycoprotein hormones in man and mouse , 1983 .

[38]  F. Byrn,et al.  The normal variabilities of the menstrual cycle. , 2009, Fertility and sterility.

[39]  K. Münstedt,et al.  Angiogenesis and vasculogenesis in pregnancy. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[40]  J. Cassels,et al.  Reduced metabolic clearance of acidic variants of human choriogonadotropin from patients with testicular cancer , 1989, Cancer.

[41]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. , 1999, Clinical chemistry.

[42]  C. Rao,et al.  Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAr cells , 1999 .

[43]  A. C. Wentz,et al.  Doubling times of human chorionic gonadotropin increase in early viable intrauterine pregnancies. , 1985, American journal of obstetrics and gynecology.

[44]  L. Cole,et al.  Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. , 2006, The Journal of reproductive medicine.

[45]  R. Pijnenborg,et al.  The uterine spiral arteries in human pregnancy: facts and controversies. , 2006, Placenta.

[46]  L. Cole,et al.  Urinary gonadotropin fragment measurements in patients with lung and esophageal disease , 1992, Journal of surgical oncology.

[47]  D. Bangham,et al.  International Reference Preparation of Human Chorionic Gonadotrophin for Immunoassay: potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the alpha and beta subunits of human chorionic gonadotrophin for immunoassay. , 1980, The Journal of endocrinology.

[48]  W. Regelson Have we found the “definitive cancer biomarker”?. The diagnostic and therapeutic implications of human chorionic gonadotropin‐beta expression as a key to malignancy , 1995, Cancer.

[49]  D. Blithe,et al.  Metabolic Clearance Rate and Urinary Clearance of Purified β-Core , 1989 .

[50]  G. Tregear,et al.  The nucleotide sequences of baboon chorionic gonadotropin beta-subunit genes have diverged from the human. , 1986, Gene.

[51]  L. Cole,et al.  Detection of perimenopausal or postmenopausal human chorionic gonadotropin : unnecessary source of alarm , 2008 .

[52]  E. M. Bogdanove,et al.  Analysis of luteinizing hormone and follicle-stimulating hormone release kinetics during a dynamic secretory event, the postpartum preovulatory surge in the rat, based on quantitative changes in stored and circulating luteinizing hormone and follicle-stimulating hormone and metabolic clearance data , 1978, Endocrinology.

[53]  N. Wald,et al.  PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN‐A AS A SERUM MARKER , 1996, Prenatal diagnosis.

[54]  R. Iles,et al.  Ectopic hCGβ expression by epithelial cancer: Malignant behaviour, metastasis and inhibition of tumor cell apoptosis , 2007, Molecular and Cellular Endocrinology.

[55]  L. Cole,et al.  Inappropriate management of women with persistent low hCG results. , 2004, The Journal of reproductive medicine.

[56]  A. Gibbons,et al.  Solving the Brain's Energy Crisis , 1998, Science.

[57]  L. Cole,et al.  Detection of the free beta subunit of human chorionic gonadotropin (HCG) in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma. , 1983, Endocrinology.

[58]  C. Lockwood Prediction of pregnancy loss , 2000, The Lancet.

[59]  J. Campain,et al.  Chorionic gonadotropin synthesis by human tumor cell lines: examination of subunit accumulation, steady-state levels of mRNA, and gene structure. , 1989, Biochimica et biophysica acta.

[60]  D. Blithe,et al.  Disparity between β-Core Levels in Pregnancy Urine and Serum: Implications for the Origin of Urinary β-Core , 1990 .

[61]  C. Weinberg,et al.  Time of implantation of the conceptus and loss of pregnancy. , 1999, The New England journal of medicine.

[62]  I. Laurendeau,et al.  Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. , 2007, Endocrinology.

[63]  K. McCrae,et al.  SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasivess and resistance to anti‐invasive action of TGFβ , 1998, International journal of cancer.

[64]  P. E. Garrett,et al.  False-positive results for choriogonadotropin in serum. , 1983, Clinical chemistry.

[65]  A. Kobata,et al.  Different asparagine-linked sugar chains on the two polypeptide chains of human chorionic gonadotropin. , 1980, Biochemical and biophysical research communications.

[66]  L. Cole,et al.  Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. , 2001, Clinical chemistry.

[67]  M. Takeuchi,et al.  Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin. , 1999, Biochimica et biophysica acta.

[68]  L. Cole,et al.  Normal Production of Human Chorionic Gonadotropin in Perimenopausal and Menopausal Women and After Oophorectomy , 2009, International Journal of Gynecologic Cancer.

[69]  K. Bagshawe,et al.  The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. , 1968, British Journal of Cancer.

[70]  B. Zondek,et al.  Das Hormon des Hypophysenvorderlappens , 1927, Klinische Wochenschrift.

[71]  M. Okamura,et al.  [Characterization of immunoreactive hCG beta-subunit in cultured fluids of the cell lines derived from gynecologic malignant tumors]. , 1990, Nihon Sanka Fujinka Gakkai zasshi.

[72]  F. Byrn,et al.  Human chorionic gonadotropin testing for early pregnancy viability and complications. , 2003, Clinics in laboratory medicine.

[73]  L. Cole,et al.  Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. , 2001, Clinical chemistry.

[74]  D. Serr,et al.  Prospective Follow‐Up of Patients with Hydatidiform Mole , 1980, Obstetrics and gynecology.

[75]  D. Krantz,et al.  Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. , 1990, American journal of obstetrics and gynecology.

[76]  Shannon Haymond,et al.  Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. , 2005, Clinical chemistry.

[77]  R. Hartsock,et al.  Metastatic phenotype correlates with high expression of membrane‐associated complete β‐human chorionic gonadotropin in vivo , 1996, Cancer.

[78]  L. Cole,et al.  Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. , 1988, Endocrinology.

[79]  H. Fujiwara Membrane-bound peptidases regulate human extravillous trophoblast invasion. , 2007, Placenta.

[80]  T. Chard,et al.  ALPHAFETOPROTEIN AND CHORIONIC GONADOTROPIN LEVELS IN RELATION TO DOWN'S SYNDROME , 1984, The Lancet.

[81]  L. Cole,et al.  Hyperglycosylated hCG (Invasive Trophoblast Antigen) Immunoassay: a New Basis for Gestational Down Syndrome Screening , 2000 .

[82]  J. Sinkovics,et al.  Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins , 1996, Cancer.

[83]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. , 2008, Fertility and sterility.

[84]  L. Cole,et al.  Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test. , 2004, Clinical biochemistry.

[85]  S. Cunnane,et al.  The Importance of Energy and Nutrient Supply in Human Brain Evolution , 1993, Nutrition and health.

[86]  J. Hustin,et al.  Partial Mole and Triploidy: Screening Patients With First‐Trimester Spontaneous Abortion , 1996, Obstetrics and gynecology.

[87]  R. Moncayo,et al.  Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. , 1990, The Journal of clinical endocrinology and metabolism.

[88]  E. Bedrick,et al.  Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study. , 2003, American journal of obstetrics and gynecology.

[89]  L. Cole,et al.  Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity. , 1990, Gynecologic oncology.

[90]  Z. Rosenwaks,et al.  Late luteal estradiol patterns are a better prognosticator of pregnancy outcome than serial beta-human chorionic gonadotropin concentrations. , 1991, Fertility and sterility.

[91]  R. Iles,et al.  Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection? , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[92]  K. Nicolaides,et al.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. , 1992, BMJ.

[93]  A. Carter,et al.  Reproductive Biology and Endocrinology Open Access Comparative Aspects of Trophoblast Development and Placentation , 2022 .

[94]  C. Graham,et al.  Mechanism of control of trophoblast invasion in situ , 1991, Journal of cellular physiology.

[95]  R. Berkowitz,et al.  A Clinicopathologic Study of 153 Cases of Complete Hydatidiform Mole (1980-1990): Histologic Grade Lacks Prognostic Significance , 1991, Obstetrics and gynecology.

[96]  R. Iles,et al.  Reduction of bladder cancer cell growth in response to hCGbeta CTP37 vaccinated mouse serum. , 2003, Oncology research.

[97]  C. Bambra Purification and properties of baboon chorionic gonadotrophin. , 1987, Journal of reproduction and fertility.

[98]  O. Genbačev,et al.  Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG , 2002, Molecular and Cellular Endocrinology.

[99]  S. Xiong,et al.  The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGβ by DNA immunization , 2007, Cancer Immunology, Immunotherapy.

[100]  T. Chard,et al.  Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. , 1996, British journal of urology.

[101]  R. Ruddon,et al.  A kinetic comparison of the processing and secretion of the alpha beta dimer and the uncombined alpha and beta subunits of chorionic gonadotropin synthesized by human choriocarcinoma cells. , 1984, The Journal of biological chemistry.

[102]  Cartwright Ps,et al.  Ectopic pregnancy: changes in serum human chorionic gonadotropin concentration. , 1984 .

[103]  L. Cole,et al.  Phantom hCG and phantom choriocarcinoma. , 1998, Gynecologic oncology.

[104]  P. Iversen,et al.  Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer. , 2003, Current opinion in molecular therapeutics.

[105]  S. Amr,et al.  Unusual molecular forms of hCG in gestational trophoblastic neoplasia. , 1984, Annales d'Endocrinologie.

[106]  T. Hulsey,et al.  Preeclampsia and human reproduction. An essay of a long term reflection. , 2003, Journal of reproductive immunology.

[107]  M. Muyan,et al.  Secretion of chorionic gonadotropin from human trophoblasts. , 1997, Placenta.

[108]  L. Cole,et al.  Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient , 1999, Endocrine.

[109]  L. Poston,et al.  Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. , 2006, Human reproduction update.

[110]  B. Huppertz,et al.  Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia , 2003, Biology of reproduction.

[111]  A. Somogyi,et al.  hCGbeta core fragment is a metabolite of hCG: evidence from infusion of recombinant hCG. , 2000, The Journal of endocrinology.

[112]  L. Cole,et al.  HCG Tests in the Management of Gestational Trophoblastic Diseases , 2003, Clinical obstetrics and gynecology.

[113]  O. P. Bahl,et al.  Structure and location of the O-glycosidic carbohydrate units of human chorionic gonadotropin. , 1979, The Journal of biological chemistry.

[114]  David Puett,et al.  Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance , 2007, Molecular and Cellular Endocrinology.

[115]  Rinaldo Bellomo,et al.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial , 2000, The Lancet.

[116]  C. Hsieh,et al.  The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures. , 1984, The Journal of clinical endocrinology and metabolism.

[117]  M. Sauer,et al.  Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. , 2002, The Journal of endocrinology.

[118]  Luckett Wp Comparative development and evolution of the placenta in primates. , 1974, Contributions to primatology.

[119]  N. Sebire,et al.  Routine terminations of pregnancy—should we screen for gestational trophoblastic neoplasia? , 2004, The Lancet.

[120]  Peter Berger,et al.  Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. , 2003, Clinical chemistry.

[121]  H. Kliman Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. , 2000, The American journal of pathology.

[122]  U. Stenman,et al.  Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry. , 2006, Glycobiology.

[123]  M. Bracken,et al.  Choriocarcinoma incidence in the United States. , 1986, American journal of epidemiology.

[124]  J. Canick,et al.  Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome , 1988, British journal of obstetrics and gynaecology.

[125]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[126]  G. Knight,et al.  Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples. , 2004, Clinical chemistry.

[127]  A. Purdie Ectopic pregnancy. , 1963, The Practitioner.

[128]  E. Abraham,et al.  Placental Site Trophoblastic Tumor , 2003, Obstetrical & gynecological survey.

[129]  J. Wands,et al.  Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide. , 1985, Journal of immunology.

[130]  L. Cole,et al.  An oligosaccharide of the O-linked type distinguishes the free from the combined form of hCG alpha subunit. , 1984, Biochemical and biophysical research communications.

[131]  O. P. Bahl,et al.  Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin. , 1979, The Journal of biological chemistry.

[132]  M. Vidaud,et al.  Characterization of Human Villous and Extravillous Trophoblasts Isolated from First Trimester Placenta , 2001, Laboratory Investigation.

[133]  D. Blithe,et al.  Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta. , 1988, Endocrinology.

[134]  D. Coppola,et al.  Purified human chorionic gonadotropin induces apoptosis in breast cancer , 2008, Molecular Cancer Therapeutics.

[135]  L. Cole,et al.  β-Core Fragment (β-Core/UGF/UGP), a Tumor Marker: A 7-Year Report , 1996 .

[136]  C. Barbatis,et al.  Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy? , 1993, British journal of urology.

[137]  D. Blithe,et al.  Variations in the oligosaccharides on free and combined alpha-subunits of human choriogonadotropin in pregnancy. , 1985, Endocrinology.

[138]  L. Cole,et al.  The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre‐eclampsia , 2002, Prenatal diagnosis.

[139]  R. Fisher,et al.  Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. , 1993, American journal of obstetrics and gynecology.

[140]  L. Cole,et al.  Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results. , 2006, Gynecologic oncology.

[141]  R. Pijnenborg THE PLACENTAL BED , 1996 .

[142]  B. Lunenfeld,et al.  Immunology of human chorionic gonadotropin (HCG). , 1967, Vitamins and hormones.

[143]  R. Canfield,et al.  Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[144]  L. Cole,et al.  Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. , 1997, Clinical chemistry.

[145]  B. Nisula,et al.  Distribution, Metabolism, and Excretion of Human Chorionic Gonadotropin and Its Subunits in Man , 1980 .

[146]  F. Byrn,et al.  A single serum test for measuring early pregnancy outcome with high predictive value. , 2006, Clinical biochemistry.

[147]  P. Iversen,et al.  Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[148]  D. Goldstein,et al.  A radioimmunoassay method for human pituitary luteinizing hormone (LH) and human chorionic gonadotropic (HCG) using 125-I-labeled LH. , 1967, American journal of obstetrics and gynecology.

[149]  L. Cole,et al.  Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[150]  L. Cole,et al.  Between-method variation in human chorionic gonadotropin test results. , 2004, Clinical chemistry.

[151]  M. Ruvolo,et al.  Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. , 2002, Molecular biology and evolution.

[152]  R. Canfield,et al.  The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. , 1975, The Journal of biological chemistry.

[153]  V. Paradis,et al.  Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. , 1997, Cancer research.

[154]  A. Gronowski,et al.  Total β-Human Chorionic Gonadotropin Measured in Urine by an Automated Method , 2002 .

[155]  D. Grenache,et al.  Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin. , 2004, American journal of clinical pathology.

[156]  L. Hansson,et al.  Hydatidiform mole with non-metastatic pulmonary complications and a false low level of hCG. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[157]  R. Berkowitz,et al.  Management of complete molar pregnancy. , 1987, The Journal of reproductive medicine.

[158]  G. Kovalevskaya,et al.  Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss , 1998, Prenatal diagnosis.

[159]  R. Martin,et al.  Relative brain size and basal metabolic rate in terrestrial vertebrates , 1981, Nature.

[160]  L. Cole,et al.  Accuracy of home pregnancy tests at the time of missed menses. , 2004, American journal of obstetrics and gynecology.

[161]  A. Gerbes,et al.  Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors. , 1992, Cancer research.

[162]  J. Hipp,et al.  Nonhuman primate parthenogenetic stem cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[163]  L. Cole,et al.  Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma. , 2008, The Journal of reproductive medicine.

[164]  L. Cole,et al.  Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine. , 1993, American journal of obstetrics and gynecology.

[165]  K. Isselbacher,et al.  Ectopic beta-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): isolation and immunochemical characterization. , 1987, Endocrinology.

[166]  P. Ramchandani,et al.  Emergency department screening for ectopic pregnancy: a prospective US study. , 1994, Radiology.

[167]  J. M. Sutton Charge variants in serum and urine hCG. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[168]  H. Ro,et al.  Discordant human chorionic gonadotropin results: causes and solutions. , 1985 .

[169]  R. Berkowitz,et al.  Gestational trophoblastic diseases. , 1989, Seminars in oncology.

[170]  L. Cole,et al.  Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease. , 2003, American journal of obstetrics and gynecology.

[171]  B. Nisula,et al.  Metabolic and renal clearance rates of purified human chorionic gonadotropin. , 1981, The Journal of clinical investigation.

[172]  R. Hartsock,et al.  Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins , 1995, Cancer.

[173]  T. Chard,et al.  The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma. , 1998, Journal of clinical pathology.

[174]  M. Mochizuki,et al.  Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. , 1988, The Journal of biological chemistry.

[175]  Y. Udagawa,et al.  [Biological properties of two newly established cell lines (SKG-3a,3b) from a human uterine cervical epidermoid carcinoma]. , 1984, Nihon Sanka Fujinka Gakkai zasshi.

[176]  T. Maruo,et al.  Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. , 2005, The Journal of clinical endocrinology and metabolism.

[177]  R. Berkowitz,et al.  Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. , 2006, Gynecologic oncology.

[178]  J. Fiddes,et al.  The cDNA for the β-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3′-untranslated region , 1980, Nature.

[179]  R. Harris Correlation of postpartum intravenous pyelograms with clinical localization of antepartum pyelonephritis. , 1981, American journal of obstetrics and gynecology.

[180]  J. Haddow,et al.  Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening , 1994, The New England journal of medicine.

[181]  L. Cole,et al.  Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results. , 2005, Obstetrics and gynecology clinics of North America.

[182]  F. Sweep,et al.  Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios. , 2005, European journal of endocrinology.

[183]  K. Grzeschik,et al.  Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse. , 1983, Somatic cell genetics.

[184]  L. Cole,et al.  Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma , 1997, Endocrine.

[185]  L. Cole,et al.  Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. , 2006, Gynecologic oncology.

[186]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. , 1991, Endocrinology.

[187]  D. Blithe,et al.  Purification of β-Core Fragment from Pregnancy Urine and Demonstration That Its Carbohydrate Moieties Differ from Those of Native Human Chorionic Gonadotropin-β , 1988 .

[188]  Patricia A. Jacobs,et al.  Mechanism of origin of complete hydatidiform moles , 1980, Nature.

[189]  C. Rao,et al.  Clinical importance of vascular LH/hCG receptors--a review. , 2001, Reproductive biology.

[190]  S. Sasaki,et al.  Genesis of 46,XY hydatidiform mole. , 1981, American journal of obstetrics and gynecology.

[191]  K. Benirschke What's new in gestational trophoblastic disease? , 1997, General & diagnostic pathology.

[192]  R. Romero,et al.  Discriminatory hCG Zone: Its Use in the Sonographic Evaluation for Ectopic Pregnancy , 1981, Obstetrics and gynecology.

[193]  B. Nisula,et al.  Metabolic clearance rates of the subunits of human chorionic gonadotropin in man. , 1979, The Journal of clinical endocrinology and metabolism.

[194]  L. Cole,et al.  Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results. , 2008, The Journal of reproductive medicine.

[195]  L. Cole,et al.  Hyperglycosylated hCG. , 2007, Placenta.

[196]  D. C. Harris,et al.  Crystal structure of human chorionic gonadotropin , 1994, Nature.

[197]  L. Cole,et al.  Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. , 2003, Clinical biochemistry.

[198]  D. Kniss,et al.  Characterization of a TGFβ-responsive human trophoblast-derived cell line , 2001 .

[199]  Kohorn Ei Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. , 1982 .

[200]  P. J. Delves,et al.  Designing a new generation of anti-hCG vaccines for cancer therapy , 2007, Molecular and Cellular Endocrinology.

[201]  K. Spencer,et al.  First‐trimester free beta (hCG) screening for Down syndrome , 1993, Prenatal diagnosis.

[202]  R. Romero,et al.  A Method of Screening for Ectopic Pregnancy and Its Indications , 1981, Obstetrics and gynecology.

[203]  E. Kohorn Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. , 2002, Gynecologic oncology.

[204]  L. Cole,et al.  Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. , 2006, Gynecologic oncology.

[205]  C. Rao,et al.  Use of the rat model to study hCG/LH effects on uterine blood flow. , 2001, Seminars in Reproductive Medicine.

[206]  L. Cole,et al.  False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations , 2000, The Lancet.

[207]  P. Cartwright,et al.  Ectopic Pregnancy: Changes in Serum Human Chorionic Gonadotropin Concentration , 1984, Obstetrics and gynecology.

[208]  C. Cunningham-Rundles,et al.  Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency , 2005, Clinical and experimental immunology.

[209]  J. Foidart,et al.  Effect of Matrigel on Human Extravillous Trophoblasts Differentiation: Modulation of Protease Pattern Gene Expression1 , 2002, Biology of reproduction.

[210]  M. Seckl,et al.  Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG , 2007, Molecular and Cellular Endocrinology.

[211]  S. Karmakar,et al.  Regulation of Trophoblast Invasion by IL‐1β and TGF‐ β1 , 2002 .

[212]  R. Berkowitz,et al.  Gestational trophoblastic disease , 1995, Cancer.

[213]  PierreYvesRobillard,et al.  Preeclampsia/Eclampsia and the Evolution of the Human Brain , 2003 .

[214]  L. Sokoll,et al.  Use of serum FSH to identify perimenopausal women with pituitary hCG. , 2008, Clinical chemistry.

[215]  R. Shownkeen,et al.  Physicochemical and immunological characterization of an HCG-like substance from human pituitary glands , 1980, Nature.

[216]  C. Haglund,et al.  Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. , 1992, Cancer research.

[217]  P. Delves,et al.  Vaccines for the control of reproduction--status in mammals, and aspects of comparative interest. , 2005, Developments in biologicals.

[218]  J. Schaffer,et al.  Bilateral ureteric obstruction of a partially duplicated collecting system improves after surgical correction of procidentia: a case report. , 2008, The Journal of reproductive medicine.

[219]  S. Birken,et al.  Isolation and characterization of human pituitary chorionic gonadotropin. , 1996, Endocrinology.

[220]  K. Preissner,et al.  Characterization of human chorionic gonadotropin as a novel angiogenic factor. , 2002, The Journal of clinical endocrinology and metabolism.

[221]  D. Blithe,et al.  Disparity between beta-core levels in pregnancy urine and serum: implications for the origin of urinary beta-core. , 1990, The Journal of clinical endocrinology and metabolism.

[222]  M. Seckl,et al.  Choriocarcinoma and partial hydatidiform moles , 2000, The Lancet.

[223]  I. Wilmut,et al.  Maternal and embryonic factors associated with prenatal loss in mammals. , 1986, Journal of reproduction and fertility.

[224]  G T Ross,et al.  A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. , 1972, American journal of obstetrics and gynecology.

[225]  M. Ascoli,et al.  On the structure of the luteinizing hormone/chorionic gonadotropin receptor. , 1989, Endocrine reviews.

[226]  M. Bogart,et al.  Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities , 1987, Prenatal diagnosis.

[227]  E. Kohorn Hydatidiform Mole and Gestational Trophoblastic Disease in Southern Connecticut , 1982, Obstetrics and gynecology.

[228]  K. Menon,et al.  Regulation of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Expression: A Perspective1 , 2004, Biology of reproduction.

[229]  J. Guibourdenche,et al.  Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies. , 2007, Endocrinology.

[230]  D. Blithe,et al.  Metabolic clearance rate and urinary clearance of purified beta-core. , 1989, The Journal of clinical endocrinology and metabolism.

[231]  G. Braunstein,et al.  First-trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders. , 1978, American journal of obstetrics and gynecology.

[232]  U. Surti,et al.  The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.

[233]  L. Cole,et al.  Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. , 1994, The Journal of reproductive medicine.

[234]  L. Cole,et al.  Discordant results in human chorionic gonadotropin assays. , 1992, Clinical chemistry.

[235]  A. Gronowski,et al.  Method evaluation for total beta-human chorionic gonadotropin using urine and the ADVIA Centaur. , 2003, Clinical Chemistry.

[236]  L. Wide,et al.  An immunological pregnancy test. , 1960, Acta endocrinologica.

[237]  N. Ajubi,et al.  Quantitative automated human chorionic gonadotropin measurement in urine using the Modular Analytics E170 module (Roche) , 2005, Clinical chemistry and laboratory medicine.

[238]  G. Braunstein,et al.  Widespread distribution of a chorionic gonadotropin-like substance in normal human tissues. , 1979, The Journal of clinical endocrinology and metabolism.

[239]  E. Jauniaux,et al.  Placental Oxidative Stress: From Miscarriage to Preeclampsia , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[240]  I. McNeish,et al.  Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[241]  J. Haddow,et al.  Hyperglycosylated‐hCG (h‐hCG) and Down syndrome screening in the first and second trimesters of pregnancy , 2007, Prenatal diagnosis.

[242]  A. Tulpule,et al.  The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. , 1996, The New England journal of medicine.

[243]  L. Cole,et al.  Normal production of human chorionic gonadotropin in menopause. , 2007, The New England journal of medicine.

[244]  K. Preissner,et al.  HCG in the regulation of placental angiogenesis. Results of an in vitro study. , 2007, Placenta.

[245]  T. Higuchi,et al.  New regulatory mechanisms for human extravillous trophoblast invasion , 2005, Reproductive medicine and biology.

[246]  G. Ott,et al.  Characterization of the new bladder cancer cell line HOK‐I: Expression of transitional, squamous and glandular differentiation patterns , 1991, International journal of cancer.

[247]  L. Cole,et al.  Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass. , 1990, Gynecologic oncology.

[248]  F. S. Hom,et al.  Study of stability of sulfadiazine sodium injection. I. Determination of solubility of sulfadiazine sodium as a function of pH in several parenteral solvent systems. , 1956, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[249]  Rao,et al.  The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. , 1992, The Journal of clinical endocrinology and metabolism.

[250]  R. Martin,et al.  Human reproduction: a comparative background for medical hypotheses. , 2003, Journal of reproductive immunology.

[251]  L. Cole,et al.  Sensitivity of over-the-counter pregnancy tests: comparison of utility and marketing messages. , 2005, Journal of the American Pharmacists Association : JAPhA.

[252]  I. Debyser,et al.  Partial hydatidiform mole in a pregnant chimpanzee (Pan troglodytes) , 1993 .

[253]  L. Cole "Background" human chorionic gonadotropin in healthy, nonpregnant women. , 2005, Clinical chemistry.

[254]  R. Canfield,et al.  Structure and significance of human luteinizing hormone-beta core fragment purified from human pituitary extracts. , 1993, Endocrinology.

[255]  R. Hussa Immunologic and physical characterization of human chorionic gonadotropin and its subunits in cultures of human malignant trophoblast. , 1977, The Journal of clinical endocrinology and metabolism.